Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer

    1. D V Faller1,2,3,4,5,6
    1. 1Cancer Center, Departments of
      2Medicine
      3Biochemistry
      4Pediatrics
      5Microbiology
      6Pathology and Laboratory Medicine, Boston University School of Medicine, 72 East Concord Street, Room K-701, Boston, Massachusetts 02118-2307, USA
    1. (Correspondence should be addressed to D V Faller at Boston University School of Medicine; Email: dfaller{at}bu.edu)

    Abstract

    Sirtuins, which are class III NAD-dependent histone deacetylases that regulate a number of physiological processes, play important roles in the regulation of metabolism, aging, oncogenesis, and cancer progression. Recently, a role for the sirtuins in the regulation of steroid hormone receptor signaling is emerging. In this mini-review, we will summarize current research into the regulation of estrogen, androgen, progesterone, mineralocorticoid, and glucocorticoid signaling by sirtuins in cancer. Sirtuins can regulate steroid hormone signaling through a variety of molecular mechanisms, including acting as co-regulatory transcription factors, deacetylating histones in the promoters of genes with nuclear receptor-binding sites, directly deacetylating steroid hormone nuclear receptors, and regulating pathways that modify steroid hormone receptors through phosphorylation. Furthermore, disruption of sirtuin activity may be an important step in the development of steroid hormone-refractory cancers.

    • Received in final form 7 December 2011
    • Accepted 12 December 2011
    • Made available online as an Accepted Preprint 12 December 2011
    | Table of Contents